Impact of different dose reduction criteria for anti‐Xa direct oral anticoagulants on bleeding complications: A single center observational study

BACKGROUND: Each direct oral anticoagulant (DOAC) has different dose reduction criteria. Here, we evaluated the differences in the doses of three anti‐Xa DOACs and clinical events based on the dose reduction criteria in patients with atrial fibrillation (AF). METHODS: Consecutive AF patients prescri...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukaya, Hidehira, Oikawa, Jun, Nakamura, Hironori, Igarashi, Tazuru, Fujiishi, Tamami, Ishizue, Naruya, Yoshizawa, Tomoharu, Satoh, Akira, Kishihara, Jun, Niwano, Shinichi, Ako, Junya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237315/
https://www.ncbi.nlm.nih.gov/pubmed/35785369
http://dx.doi.org/10.1002/joa3.12716

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237315/
https://www.ncbi.nlm.nih.gov/pubmed/35785369
http://dx.doi.org/10.1002/joa3.12716

Ejemplares similares